THTX
Closed
Theratechnologies Inc.
2.3
-0.1 (-4.24%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.36
Day's Range: 2.29 - 2.355
Send
sign up or login to leave a comment!
When Written:
0.8074
Theratechnologies Inc. is a biopharmaceutical company that specializes in the development and commercialization of innovative therapies for people living with HIV/AIDS. The company was founded in 1993 and is based in Montreal, Canada.
Theratechnologies’ flagship product is EGRIFTA® (tesamorelin for injection), a growth hormone-releasing factor (GRF) analog that is used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. The company also has a pipeline of other potential treatments for HIV and other medical conditions.
Theratechnologies is listed on the Toronto Stock Exchange (TSX: TH) and the NASDAQ Global Market (NASDAQ: THTX). The company has partnerships with pharmaceutical companies such as TaiMed Biologics, and has received funding from government organizations such as the Canadian Institutes of Health Research (CIHR) and the National Institutes of Health (NIH).
Theratechnologies’ mission is to improve the lives of people living with HIV/AIDS by providing innovative therapies that address unmet medical needs.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Theratechnologies’ flagship product is EGRIFTA® (tesamorelin for injection), a growth hormone-releasing factor (GRF) analog that is used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. The company also has a pipeline of other potential treatments for HIV and other medical conditions.
Theratechnologies is listed on the Toronto Stock Exchange (TSX: TH) and the NASDAQ Global Market (NASDAQ: THTX). The company has partnerships with pharmaceutical companies such as TaiMed Biologics, and has received funding from government organizations such as the Canadian Institutes of Health Research (CIHR) and the National Institutes of Health (NIH).
Theratechnologies’ mission is to improve the lives of people living with HIV/AIDS by providing innovative therapies that address unmet medical needs.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








